SKY_1170x120_11-16-20

Pharmaceutical Care Management Association (PCMA)

PCMA on National Diabetes Month: PBMs lowering insulin costs, providing support to patients

PCMA on National Diabetes Month: PBMs lowering insulin costs, providing support to patients

WASHINGTON — In recognition of National Diabetes Month, the Pharmaceutical Care Management Association (PCMA) is outlining how pharmacy benefit managers, PBMs, are working to lower insulin costs and creating programs to support people with diabetes and improve health outcomes. “PBMs have been able to moderate insulin costs for most people with insurance,” said PCMA president and CEO

Groups praise high court for hearing Rutledge case

Groups praise high court for hearing Rutledge case

ALEXANDRIA, Va. — Groups ranging from the National Community Pharmacists Association (NCPA) to the Food Industry Association (FMI) have applauded the Supreme Court for hearing Rutledge v. Pharmaceutical Care Management Association (PCMA). This historic case seeks to clarify whether states can regulate pharmacy benefit managers, which manage prescription drug benefits for health insurers, Medicare Part

PBMs continue to keep Medicare part D premiums affordable

PBMs continue to keep Medicare part D premiums affordable

WASHINGTON— Pharmaceutical Care Management Association president and CEO JC Scott issued the following statement on the open enrollment season for the Medicare Part D prescription drug benefit: “As open enrollment begins, we are encouraged to see the continued trend of affordability and low premiums for seniors under Medicare Part D. This trend in affordability is due

PCMA issues statement on Medicare Part D premiums

PCMA issues statement on Medicare Part D premiums

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Administration’s announcement on 2021 Medicare Part D premiums: “PCMA applauds the Administration for its work continuing the success of the Part D program. Today’s announcement shows that the 2021 and 2020 average basic premiums are the second

CMA issues statement on Administration’s executive order on Rx drug pricing

CMA issues statement on Administration’s executive order on Rx drug pricing

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued the following statement on the Administration’s Executive Order to resurrect the rebate rule: “The Administration’s decision last year to withdraw a proposed regulation on prescription drug rebates was the right decision. Reviving a rebate reform proposal now does not address the underlying

PCMA applauds Trump Administration on new program to reduce insulin costs for medicare enrollees  

PCMA applauds Trump Administration on new program to reduce insulin costs for medicare enrollees  

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued on Tuesday the following statement applauding the Administration’s initiative, announced today, to reduce insulin costs for Medicare enrollees: “We commend the Administration for allowing Part D plan sponsors to offer a new, voluntary Medicare Part D plan, starting in 2021, under which

PCMA applauds Maryland for enacting Rx drug price transparency legislation

PCMA applauds Maryland for enacting Rx drug price transparency legislation

WASHINGTON — The Pharmaceutical Care Management Association (PCMA)  issued on Friday the following statement applauding the Maryland legislature and Governor Larry Hogan for enacting first-of-its-kind legislation, HB 978/SB 915, to increase transparency in the prescription drug supply chain. The legislation, sponsored by Delegate Ariana Kelly and Senator Benjamin Kramer, will give Maryland policymakers and the

PCMA files brief in Rutledge versus PCMA

PCMA files brief in Rutledge versus PCMA

WASHINGTON — On Wednesday, the Pharmaceutical Care Management Association (PCMA) filed its brief with the U.S. Supreme Court in the case of Rutledge versus PCMA, arguing that a misguided Arkansas law creates inefficiencies in employer-sponsored health plans and threatens access to prescription drugs. The brief comes in advance of anticipated oral arguments next month. Unique state

PCMA names new staff addition to state affairs

PCMA names new staff addition to state affairs

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) has announced that Regina Stivers as PCMA’s newest staff addition. Stivers joins PCMA as director, state affairs. She brings a tremendous amount of experience, having worked in both federal and state government and in the private sector overseeing economic development. Before joining PCMA, Regina served as both

Study: PBM care management programs improve health outcomes

Study: PBM care management programs improve health outcomes

WASHINGTON — As prescription drug spending is poised to reach as much as $5 trillion during the next decade, new data find that pharmacy benefit managers’ (PBMs’) proven cost savings and patient care management tools should reduce prescription drug costs for health plan sponsors and consumers by an average of 20%, or more than $1

Jon Roberts of CVS Health becomes chairman of PCMA board

Jon Roberts of CVS Health becomes chairman of PCMA board

WASHINGTON — On Wednesday, the Pharmaceutical Care Management Association (PCMA) announced that Jon Roberts, executive vice president and chief operating officer of CVS Health becomes chairman of PCMA’s board of directors. “I’m honored to serve as chairman of the PCMA board of directors, supporting the association’s efforts to change the dialogue around prescription drugs with a

PCMA issues statement on HHS report on Rx drug rebates

PCMA issues statement on HHS report on Rx drug rebates

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Health and Human Services Officer of Inspector General report (OIG) on prescription drug rebates in Medicare Part D. “Today’s OIG report further dispels the false narrative about PBM-negotiated rebates and confirms that rebates lead to lower prescription

PBMs support transparency for consumers, health plan sponsors, policymakers

PBMs support transparency for consumers, health plan sponsors, policymakers

WASHINGTON — The Pharmaceutical Care Management Association (PCMA) issued the following statement on today’s action by the House Energy and Commerce Subcommittee on Health drug pricing transparency legislation: PCMA applauds the Energy and Commerce Subcommittee on Health for advancing legislation promoting real-time benefit tools to give prescribers and patients at the point of prescribing information on

PCMA issues statement on proposed Rx drug rebate rule  

PCMA issues statement on proposed Rx drug rebate rule  

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott issued the following statement on the Administration’s decision to withdraw the proposed rule on prescription drug rebates: “We understand that high prescription drug prices are a burden for too many Americans. There is still a problem of affordability for consumers that